ReviewTherapeutics and clinical risk management2015

Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes.

Nishanth Vallumsetla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.